Bombesin receptor subtype-3 (BRS-3) regulates glucose-stimulated insulin secretion in pancreatic islets across multiple species

Endocrinology

Volumn 152, Issue 11, 2011, Pages 4106-4115

  Feng, Yue ^a   Guan, Xiao Ming ^a   Li, Jing ^a   Metzger, Joseph M ^a   Zhu, Yonghua ^a   Juhl, Kirstine ^a   Zhang, Bei B ^a   Thornberry, Nancy A ^a   Reitman, Marc L ^a   Zhou, Yun Ping ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; BAG 1 PROTEIN; BANTAG 1 PROTEIN; BOMBESIN ANTAGONIST; BOMBESIN RECEPTOR; BOMBESIN RECEPTOR SUBTYPE 3; GLUCOSE; INSULIN; MESSENGER RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CONTROLLED STUDY; DOG; GENE SILENCING; GLUCOSE HOMEOSTASIS; HUMAN; HUMAN CELL; INSULIN RELEASE; INSULINOMA; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RHESUS MONKEY;

ANIMALS; DOGS; GLUCOSE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MACACA MULATTA; MICE; RATS; RECEPTORS, BOMBESIN;

EID: 80054917910     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1440     Document Type: Article

References (42)

1. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, Williams DE, Gregg EW, Bainbridge KE, Saydah SH, Geiss LS 2009 Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 32:287-294
2. Flegal KM, Carroll MD, Ogden CL, Curtin LR 2010 Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303: 235-241
3. Rhodes CJ 2005 Type 2 diabetes-a matter of β-cell life and death? Science 307:380-384 (Pubitemid 40139973)
4. Prentki M, Nolan CJ 2006 Islet β cell failure in type 2 diabetes. J Clin Invest 116:1802-1812 (Pubitemid 44033300)
5. DeFronzo RA, Ratner RE, Han J, Kim DD, Fineman MS, Baron AD 2005 Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care 28:1092-1100 (Pubitemid 40616618)
6. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B 2009 Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 32:193-203
7. Lovshin JA, Drucker DJ 2009 Incretin-based therapies for type 2 diabetes mellitus. Nat Rev Endocrinol 5:262-269
8. Anastasi A, Erspamer V, Bucci M 1971 Isolation and structure of bombesin and alytesin, 2 analogous active peptides from the skin of the European amphibians Bombina and Alytes. Experientia 27:166-167
9. Gonzalez N, Moody TW, Igarashi H, Ito T, Jensen RT 2008 Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states. Curr Opin Endocrinol Diabetes Obes 15:58-64
10. Jensen RT, Battey JF, Spindel ER, Benya RV 2008 International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol Rev 60:1-42 (Pubitemid 351439216)
11. Sano H, Feighner SD, Hreniuk DL, Iwaasa H, Sailer AW, Pan J, Reitman ML, Kanatani A, Howard AD, Tan CP 2004 Characterization of the bombesin-like peptide receptor family in primates. Genomics 84:139-146 (Pubitemid 38760137)
12. Ohki-Hamazaki H, Watase K, Yamamoto K, Ogura H, Yamano M, Yamada K, Maeno H, Imaki J, Kikuyama S, Wada E, Wada K 1997 Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity. Nature 390:165-169 (Pubitemid 27507984)
13. Maekawa F, Quah HM, Tanaka K, Ohki-Hamazaki H 2004 Leptin resistance and enhancement of feeding facilitation by melanin-concentrating hormone in mice lacking bombesin receptor subtype-3. Diabetes 53:570-576 (Pubitemid 38270624)
14. Ladenheim EE, Hamilton NL, Behles RR, Bi S, Hampton LL, Battey JF, Moran TH 2008 Factors contributing to obesity in bombesin receptor subtype-3-deficient mice. Endocrinology 149:971-978 (Pubitemid 351397925)
15. Porcher C, Juhem A, Peinnequin A, Bonaz B 2005 Bombesin receptor subtype-3 is expressed by the enteric nervous system and by interstitial cells of Cajal in the rat gastrointestinal tract. Cell Tissue Res 320:21-31 (Pubitemid 40543759)
16. Guan XM, Chen H, Dobbelaar PH, Dong Y, Fong TM, Gagen K, Gorski J, He S, Howard AD, Jian T, Jiang M, Kan Y, Kelly TM, Kosinski J, Lin LS, Liu J, Marsh DJ, Metzger JM, Miller R, Nargund RP, Palyha O, Shearman L, Shen Z, Stearns R, Strack AM, Stribling S, Tang YS, Wang SP, White A, Yu H, Reitman ML 2010 Regulation of energy homeostasis by bombesin receptor subtype-3: selective receptor agonists for the treatment of obesity. Cell Metab 11:101-112
17. Liu J, He S, Jian T, Dobbelaar PH, Sebhat IK, Lin LS, Goodman A, Guo C, Guzzo PR, Hadden M, Henderson AJ, Pattamana K, Ruenz M, Sargent BJ, Swenson B, Yet L, Tamvakopoulos C, Peng Q, Pan J, Kan Y, Palyha O, Kelly TM, Guan XM, Howard AD, Marsh DJ, Metzger JM, Reitman ML, Wyvratt MJ, Nargund RP 2010 Synthesis andSARof derivatives based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesity. Bioorg Med Chem Lett 20:2074-2077
18. Fleischmann A, Läderach U, Friess H, Buechler MW, Reubi JC 2000 Bombesin receptors in distinct tissue compartments of human pancreatic diseases. Lab Invest 80:1807-1817 (Pubitemid 32012750)
19. Nakamichi Y, Wada E, Aoki K, Ohara-Imaizumi M, Kikuta T, Nishiwaki C, Matsushima S, Watanabe T, Wada K, Nagamatsu S 2004 Functions of pancreatic β cells and adipocytes in bombesin receptor subtype-3-deficient mice. Biochem Biophys Res Commun 318:698-703 (Pubitemid 38624210)
20. Matsumoto K, Yamada K, Wada E, Hasegawa T, Usui Y, Wada K 2003 Bombesin receptor subtype-3 modulates plasma insulin concentration. Peptides 24:83-90 (Pubitemid 36165178)
21. He S, Dobbelaar PH, Liu J, Jian T, Sebhat IK, Lin LS, Goodman A, Guo C, Guzzo PR, Hadden M, Henderson AJ, Ruenz M, Sargent BJ, Yet L, Kelly TM, Palyha O, Kan Y, Pan J, Chen H, Marsh DJ, Shearman LP, Strack AM, Metzger JM, Feighner SD, Tan C, et al. 2010 Discovery of substituted biphenyl imidazoles as potent, bioavailable bombesin receptor subtype-3 agonists. Bioorg Med Chem Lett 20:1913-1917
22. Sebhat IK, Franklin C, Lo M, Chen D, Jewell JP, Miller R, Pang Q, Palyha O, Kan Y, Kelly TM, Guan X-M, Marsh DJ, Metzger JM, Lyons K, Dragovic J, Guzzo PR, Reitman ML, Nargund RP, Wyvratt MJ, Lin LS, Discovery of (2S)-1,1,1-trifluoro-2-[4-(1H-pyrazol-1- yl)phenyl]-3-(4-{[1-(trifluoromethyl) cyclopropyl]methyl}-1H-imidazol- 2-yl)propan-2-ol (MK-5046), a potent, selective bombesin receptor subtype-3 (BRS-3) agonist for the treatment of obesity. ACS Med Chem Lett 2:43-47
23. Hohmeier HE, Mulder H, Chen G, Henkel-Rieger R, Prentki M, Newgard CB 2000 Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes 49:424-430 (Pubitemid 30131788)
24. Waddleton D, Wu W, Feng Y, Thompson C, Wu M, Zhou YP, HowardA, Thornberry N, Li J, Mancini JA 2008 Phosphodiesterase 3 and 4 comprise the major cAMP metabolizing enzymes responsible for insulin secretion in INS-1 (832/13) cells and rat islets. Biochem Pharmacol 76:884-893
25. Miyazaki J, Araki K, Yamato E, Ikegami H, Asano T, Shibasaki Y, Oka Y, Yamamura K 1990 Establishment of a pancreatic β cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127: 126-132 (Pubitemid 20228111)
26. Lacy PE, Kostianovsky M 1967 Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16:35-39
27. Herrington J, Zhou YP, Bugianesi RM, Dulski PM, Feng Y, Warren VA, Smith MM, Kohler MG, Garsky VM, Sanchez M, Wagner M, Raphaelli K, Banerjee P, Ahaghotu C, Wunderler D, Priest BT, Mehl JT, Garcia ML, McManus OB, Kaczorowski GJ, Slaughter RS 2006 Blockers of the delayed-rectifier potassium current in pancreatic beta-cells enhance glucose-dependent insulin secretion. Diabetes 55: 1034-1042 (Pubitemid 44100179)
28. Ronnebaum SM, Jensen MV, Hohmeier HE, Burgess SC, Zhou YP, Qian S, MacNeil D, Howard A, Thornberry N, Ilkayeva O, Lu D, Sherry AD, Newgard CB 2008 Silencing of cytosolic or mitochondrial isoforms of malic enzyme has no effect on glucose-stimulated insulin secretion from rodent islets. J Biol Chem 283:28909-28917
29. Ahrén B 2009 Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nat Rev Drug Discov 8:369-385
30. Asfari M, Janjic D, Meda P, Li G, Halban PA, Wollheim CB 1992 Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 130:167-178
31. Guan XM, Metzger JM, Yang L, Raustad KA, Wang SP, Spann SK, Kosinski JA, Yu H, Shearman LP, Faidley TD, Palyha O, Kan Y, Kelly TM, Sebhat I, Lin LS, Dragovic J, Lyons KA, Craw S, Nargund RP, Marsh DJ, Strack AM, Reitman ML 2011 Anti-Obesity Effect of MK-5046, a novel bombesin receptor subtype-3 agonist. J Pharmacol Exp Ther 336:356-364
32. Tyrberg B, Andersson A, Borg LA 2001 Species differences in susceptibility of transplanted and cultured pancreatic islets to the β-cell toxin alloxan. Gen Comp Endocrinol 122:238-251 (Pubitemid 32477055)
33. Eizirik DL, Pipeleers DG, Ling Z, Welsh N, Hellerström C, Andersson A 1994 Major species differences between humans and rodents in the susceptibility to pancreatic β-cell injury Proc Natl Acad Sci USA 91:9253-9256 (Pubitemid 24297892)
34. Haitina T, Fredriksson R, Foord SM, Schiöth HB, Gloriam DE 2009 The G protein-coupled receptor subset of the dog genome is more similar to that in humans than rodents. BMC Genomics 10:24-33
35. Tan CP, Feng Y, Zhou YP, Eiermann GJ, Petrov A, Zhou C, Lin S, Salituro G, Meinke P, Mosley R, Akiyama TE, Einstein M, Kumar S, Berger JP, Mills SG, Thornberry NA, Yang L, Howard AD 2008 Selective small-molecule agonists of G protein-coupled receptor 40 promote glucose-dependent insulin secretion and reduce blood glucose in mice. Diabetes 57:2211-2219
36. Negoro N, Sasaki S, Mikami S, Ito M, Suzuki M, Tsujihata Y, Ito R, Harada A, Takeuchi K, Suzuki N, Miyazaki J, Santou T, Odani T, Kanzaki N, Funami M, Tanaka T, Kogame A, Matsunaga S, Yasuma T, Momose Y 2010 Discovery of TAK-875: a potent, selective, and orally bioavailable GPR40 agonist. ACS Med Chem Lett 1:290-294
37. Gautam D, Han SJ, Hamdan FF, Jeon J, Li B, Li JH, Cui Y, Mears D, Lu H, Deng C, Heard T, Wess J 2006 A critical role for β cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Cell Metab 3:449-461 (Pubitemid 43811775)
38. Liu J, Lao ZJ, Zhang J, Schaeffer MT, Jiang MM, Guan XM, Van der Ploeg LH, Fong TM 2002 Molecular basis of the pharmacological difference between rat and human bombesin receptor subtype-3 (BRS-3). Biochemistry 41:8954-8960 (Pubitemid 34774409)
39. Lammerich HP, Busmann A, Kutzleb C, Wendland M, Seiler P, Berger C, Eickelmann P, Meyer M, Forssmann WG, Maronde E 2003 Identification and functional characterization of hemorphins VV-H-7andLVV-H-7as low-affinity agonists for the orphanbombesin receptor subtype 3. Br J Pharmacol 138:1431-1440 (Pubitemid 36609638)
40. Gbahou F, Holst B, Schwartz TW 2010 Molecular basis for agonism in the BB3 receptor-an epitope located on the interface of TM-III, -VI and -VII. J Pharmacol Exp Ther 333:51-59
41. Guettier JM, Gautam D, Scarselli M, Ruiz de Azua I, Li JH, Rosemond E, Ma X, Gonzalez FJ, Armbruster BN, Lu H, Roth BL, Wess J 2009 A chemical-genetic approach to study G protein regulation of β cell function in vivo. Proc Natl Acad Sci USA 106:19197-19202
42. Kent P, Bédard T, Khan S, Anisman H, Merali Z 2001 Bombesin-induced HPA and sympathetic activation requires CRH receptors. Peptides 22:57-65 (Pubitemid 32146684)